- Home
- NYMT vs CVRX Comparison
NYMT vs CVRX Comparison
Compare NYMT & CVRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NYMT
- CVRX
- Stock Information
- Founded
- NYMT 2003
- CVRX 2000
- Country
- NYMT United States
- CVRX United States
- Employees
- NYMT N/A
- CVRX N/A
- Industry
- NYMT Real Estate Investment Trusts
- CVRX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- NYMT Real Estate
- CVRX Health Care
- Exchange
- NYMT Nasdaq
- CVRX Nasdaq
- Market Cap
- NYMT 516.8M
- CVRX 419.8M
- IPO Year
- NYMT 2004
- CVRX 2021
- Fundamental
- Price
- NYMT $5.97
- CVRX $17.62
- Analyst Decision
- NYMT Buy
- CVRX Strong Buy
- Analyst Count
- NYMT 5
- CVRX 7
- Target Price
- NYMT $7.13
- CVRX $17.00
- AVG Volume (30 Days)
- NYMT 876.0K
- CVRX 213.8K
- Earning Date
- NYMT 02-19-2025
- CVRX 01-27-2025
- Dividend Yield
- NYMT 13.40%
- CVRX N/A
- EPS Growth
- NYMT N/A
- CVRX N/A
- EPS
- NYMT N/A
- CVRX N/A
- Revenue
- NYMT $252,541,000.00
- CVRX $47,255,000.00
- Revenue This Year
- NYMT N/A
- CVRX $31.78
- Revenue Next Year
- NYMT $45.89
- CVRX $26.42
- P/E Ratio
- NYMT N/A
- CVRX N/A
- Revenue Growth
- NYMT 139.48
- CVRX 34.38
- 52 Week Low
- NYMT $5.14
- CVRX $6.40
- 52 Week High
- NYMT $8.51
- CVRX $29.23
- Technical
- Relative Strength Index (RSI)
- NYMT 49.00
- CVRX 76.79
- Support Level
- NYMT $5.53
- CVRX $13.82
- Resistance Level
- NYMT $5.99
- CVRX $17.72
- Average True Range (ATR)
- NYMT 0.17
- CVRX 0.88
- MACD
- NYMT -0.01
- CVRX 0.49
- Stochastic Oscillator
- NYMT 51.16
- CVRX 98.09
About NYMT New York Mortgage Trust Inc.
New York Mortgage Trust Inc is a real estate investment trust for federal income tax purposes, in the business of acquiring, investing in, financing and managing mortgage-related and residential housing-related assets. The company's investment portfolio consists of Structured multi-family property investments such as multi-family CMBS an preferred equity in, and mezzanine loans to owners of multi-family properties. Distressed residential assets such as residential mortgage loans sourced from distressed markets and non-Agency RMBS. Second mortgages, Agency RMBS, and certain other mortgage-related and residential housing-related assets.
About CVRX CVRx Inc.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.